IndraLab
Statements
Hydroxychloroquine activates azithromycin. 14 / 14
|
1
13
reach
"A substantial reduction in viral load and more rapid virus elimination was seen in patients treated with a combination of hydroxychloroquine and azithromycin; however, the majority of patients treated with hydroxychloroquine alone continued to display symptoms of upper or lower respiratory tract infections [XREF_BIBR]."
reach
"They reported that the duration of hospital stay was higher in patients who were treated with both hydroxychloroquine and azithromycin compared to those who were only treated with hydroxychloroquine; but this difference was non significant (10.3 vs 9.6, Odds ratio :0.7, 95% CI : -0.6 -1.9) XREF_BIBR."
reach
"Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.The anti-malarial 4-aminoquinoline drugs chloroquine (CQ) and hydroxychloroquine (HCQ) as well as the antibiotic azithromycin (AZ) have gained much attention as potential therapies."
reach
"On the other hand, HCQ was then added at a concentration of 6 μg/mL to each increased levels of DOXY i.e. 0.2, 2, 10, 100, and 400 μg/mL to produce HCQ 6 μg/mL + DOXY.Fig 9: The cytotoxicities of Favipiravir (FAVI) and Azithromycin (AZI) as a single drug (left) and dual drug combination in constant and non-constant ratios (right) analysed by using CompuSyn Software (n = 3)."
reach
"This same study observed no improvements in pulmonary images or in the average length of hospital stay after combining with other antivirals (Arbidol + Ritonavir or Interferon + LPV/r or Interferon + Darunavir).3.4.2 Hydroxychloroquine and Azithromycin Patients treated with Hydroxychloroquine (HCQ) (ID : 26402) demonstrated areduction in radiological progression of the disease compared to conventional treatment (OR for radiological disease progression during treatment was 0.31; 95% CI, [0, 110.9])."
| DOI